• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24038 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     Health Quality Ontario (HQO) The appropriate use of neuroimaging in the diagnostic work-up of dementia: an economic literature review and cost-effectiveness analysis
2014     NIHR Horizon Scanning Centre (NIHR HSC) Idalopirdine for Alzheimer's disease as an adjunct to acetylcholinesterase inhibitor therapy
2014     Blue Cross Blue Shield Association (BCBS) Critical issues in robotic surgery
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Techniques and products for surgical hand antisepsis: a review of guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cabozantinib - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Total prosthetic replacement of the temporomandibular joint. NICE interventional procedures guidance 500
2014     Health Quality Ontario (HQO) Multiple intravenous infusions phase 2b: laboratory study
2014     NIHR Horizon Scanning Centre (NIHR HSC) Pimavanserin tartrate for psychosis associated with Parkinson's disease - first line
2014     Blue Cross Blue Shield Association (BCBS) Gene expression profiling in women with lymph node‒negative breast cancer to select adjuvant chemotherapy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Obesity management interventions delivered in primary care for patients with hypertension or cardiovascular disease: a review of clinical effectiveness
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A14-19 (mirabegron)]
2014     National Institute for Health and Care Excellence (NICE) Minimally invasive video-assisted thyroidectomy. NICE interventional procedures guidance 499
2014     Health Quality Ontario (HQO) Multiple intravenous infusions phase 2a: Ontario survey
2014     NIHR Horizon Scanning Centre (NIHR HSC) Daclizumab High Yield Process for relapsing forms of multiple sclerosis – first or second line
2014     Blue Cross Blue Shield Association (BCBS) Percutaneous mitral valve repair
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Combination use of insulin and fipeptidyl peptidase-4 (DDP-4) inhibitors in Type 2 diabetes: clinical effectiveness
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A14-18 (simeprevir)]
2014     National Institute for Health and Care Excellence (NICE) Minimally invasive video-assisted parathyroidectomy. NICE interventional procedures guidance 501
2014     Health Quality Ontario (HQO) Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study
2014     Blue Cross Blue Shield Association (BCBS) Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis
2014     NIHR Horizon Scanning Centre (NIHR HSC) Fingolimod for chronic inflammatory demyelinating polyneuropathy – second line
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Retrieval and redistribution of unused home care supplies: safety, cost-effectiveness, and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Obinituzumab - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Assessing motility of the gastrointestinal tract using a wireless capsule. NICE interventional procedures guidance 502
2014     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
2014     Health Quality Ontario (HQO) Frequency of testing for dyslipidemia: an evidence-based analysis
2014     Blue Cross Blue Shield Association (BCBS) Artificial lumbar disc arthroplasty
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ocrelizumab for relapsing-remitting multiple sclerosis
2014     Blue Cross Blue Shield Association (BCBS) Intra-articular hyaluronic acid for osteoarthritis of the knee
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone for NYHA functional class III/ IV heart failure and left-ventricular systolic dysfunction: clinical and cost-effectiveness
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Eribulin (new therapeutic indication) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Endoscopic radiofrequency ablation for Barrett's oesophagus with low-grade dysplasia or no dysplasia. NICE interventional procedures guidance 496
2014     Health Quality Ontario (HQO) Frequency of testing for dyslipidemia: a systematic review and budget impact analysis
2014     Blue Cross Blue Shield Association (BCBS) CYP2D6 pharmacogenomics of tamoxifen treatment
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ocrelizumab for primary progressive multiple sclerosis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Off-label use of 5HT3 antagonists: clinical evidence and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Empagliflozin - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus. NICE interventional procedures guidance 497
2014     Health Quality Ontario (HQO) Multiple intravenous infusions phases 2a and 2b: OHTAC recommendation
2014     Blue Cross Blue Shield Association (BCBS) Transcranial magnetic stimulation for depression
2014     NIHR Horizon Scanning Centre (NIHR HSC) Curelator Headache™ digital platform for adults with migraine
2014     Blue Cross Blue Shield Association (BCBS) Fecal DNA analysis for colorectal cancer screening
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Nebulized Lidocaine for patients with nasal trauma: clinical effectiveness and guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Canagliflozin/metformin - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Powered microdebrider turbinoplasty for inferior turbinate hypertrophy. NICE interventional procedures guidance 498
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Building planning and infection control: hand hygiene dispensers and individual bathrooms in residential and long-term care centres]
2014     Blue Cross Blue Shield Association (BCBS) Percutaneous tibial nerve stimulation for the treatment of voiding dysfunction
2014     NIHR Horizon Scanning Centre (NIHR HSC) SensiumVitals® vital signs monitoring patch
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fluticasone furoate/vilanterol (as trifenatate) (Relvar® Ellipta®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ankle braces for the prevention of injury in sport: clinical effectiveness
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Apixaban (extension of approval) - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Endoscopic saphenous vein harvest for coronary artery bypass grafting. NICE interventional procedures guidance 494
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Efficacy of neglect interventions for Indigenous children, families and communities]
2014     Blue Cross Blue Shield Association (BCBS) Gene expression analysis for prostate cancer management
2014     NIHR Horizon Scanning Centre (NIHR HSC) Peramivir for acute uncomplicated influenza in adults
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Velaglucerase alfa
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ketorolac for pain management: a review of the clinical evidence
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nalmefene - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Radiofrequency tissue reduction for turbinate hypertrophy. NICE interventional procedures guidance 495
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Public policies for the coverage of continuous positive airway pressure devices for the treatment of obstructive sleep apnea]
2014     Blue Cross Blue Shield Association (BCBS) Myocardial sympathetic innervation imaging in heart failure
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ivacaftor (Kalydeco) for an additional 8 mutations in cystic fibrosis (licence extension)
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Emtricitabine/rilpivirine/tenofovir disoproxil (as fumarate) (Eviplera®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Cystoscopy for the diagnosis of patients with urological issues: guidelines
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ivacaftor - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Teriflunomide for treating relapsing–remitting multiple sclerosis. NICE technology appraisal guidance 303
2014     National Institute for Health and Care Excellence (NICE) Gastroelectrical stimulation for gastroparesis. NICE interventional procedures guidance 489
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Real-time magnetic resonance imaging (MRI)-guided radiation therapy]
2014     Blue Cross Blue Shield Association (BCBS) Artificial intervertebral disc arthroplasty for treatment of degenerative disc disease of the cervical spine
2014     NIHR Horizon Scanning Centre (NIHR HSC) InterVapor® System for the treatment of severe emphysema
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Imatinib (Glivec®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Teduglutide - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip. NICE technology appraisal guidance 304
2014     National Institute for Health and Care Excellence (NICE) Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limb. NICE interventional procedures guidance 487
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Management of the extravasation of antineoplastic agents]
2014     Blue Cross Blue Shield Association (BCBS) Artificial pancreas device systems
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ivermectin 1% topical cream for papulopustular rosacea
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Eltrombopag (Revolade®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Interferon-free regimens for chronic hepatitis C genotype 1
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Propranolol - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion. NICE technology appraisal guidance 305
2014     National Institute for Health and Care Excellence (NICE) Arthroscopic radiofrequency chondroplasty for discrete chondral defects of the knee. NICE interventional procedures guidance 493
2014     NIHR Health Technology Assessment programme Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds
2014     Blue Cross Blue Shield Association (BCBS) Special report: screening asymptomatic women with dense breasts and normal mammograms for breast cancer
2014     NIHR Horizon Scanning Centre (NIHR HSC) Thymosin beta-4 for epidermolysis bullosa
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Lipegfilgrastim (Lonquex®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Obesity interventions delivered in primary care for patients with diabetes: a review of clinical effectiveness
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Daclatasvir - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2014     National Institute for Health and Care Excellence (NICE) Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma. NICE technology appraisal guidance 306
2014     National Institute for Health and Care Excellence (NICE) Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults. NICE interventional procedures guidance 482
2014     NIHR Health Technology Assessment programme European network for Health Technology Assessment Joint Action (EUnetHTA JA): a process evaluation performed by questionnaires and documentary analysis
2014     NIHR Health Technology Assessment programme The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials
2014     NIHR Horizon Scanning Centre (NIHR HSC) CelluTome™ epidermal harvesting system for autologous skin grafting
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Delta-9-tetrahydrocannabinol/cannabidiol (Sativex®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Interferon-free regimens for genotype 1 chronic hepatitis C: a review of the clinical evidence and cost-effectiveness
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission A14-21 (Fingolimod)]
2014     National Institute for Health and Care Excellence (NICE) Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy. NICE technology appraisal guidance 307
2014     National Institute for Health and Care Excellence (NICE) Insertion of a magnetic bead band for faecal incontinence. NICE interventional procedures guidance 483
2014     NIHR Health Technology Assessment programme Maximising the value of combining qualitative research and randomised controlled trials in health research: the QUAlitative Research in Trials (QUART) study a mixed methods study